Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

Several lines of reasoning suggest that the phosphorylated axonal form of the neurofilament subunit NF-H is likely to be released from damaged and diseased neurons in significant amounts. Detection of this protein in serum or CSF might therefore provide information about the presence and degree of neuronal loss. We therefore developed a sensitive NF-H ELISA capable of detecting picogram quantities of phosphorylated NF-H (pNF-H). This assay showed that soluble pNF-H immunoreactivity is readily detectable in the sera of adult rats following various types of experimental spinal cord injury (SCI) and traumatic brain injury (TBI), but is undetectable in the sera of normal animals. Here we describe details of the time course and extent of serum pNF-H expression following experimental SCI and TBI. Following SCI, serum pNF-H showed an initial peak of expression at 16h and a second, usually larger, peak at 3 days. Following TBI, lower levels of serum pNF-H were detected with a peak at 2 days post-injury. We also show that the higher levels of pNF-H released from injured spinal cord as compared to brain are in line with the approximately 20-fold higher levels of pNF-H present in spinal cord. These findings suggest that serum levels of pNF-H immunoreactivity may be used to conveniently monitor neuronal damage and degeneration in experimental and presumably clinical situations.

[1]  J. Troncoso,et al.  Phosphorylation Modulates Calpain‐Mediated Proteolysis and Calmodulin Binding of the 200‐kDa and 160‐kDa Neurofilament Proteins , 1993, Journal of neurochemistry.

[2]  A. Delacourte,et al.  Study of the 10-nm-filament fraction isolated during the standard microtubule preparation. , 1980, The Biochemical journal.

[3]  Y. Ihara,et al.  τ Is Widely Expressed in Rat Tissues , 1996 .

[4]  I. Grundke‐Iqbal,et al.  Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients , 2002, Neuroscience Letters.

[5]  W. Schlaepfer,et al.  The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. , 1985, The Journal of biological chemistry.

[6]  Douglas K. Anderson,et al.  Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation , 1999, Experimental Neurology.

[7]  Dennis W. Dickson,et al.  Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process , 2002, Acta Neuropathologica.

[8]  S. Scheff,et al.  Neuronal cell loss in the CA3 subfield of the hippocampus following cortical contusion utilizing the optical disector method for cell counting. , 1997, Journal of neurotrauma.

[9]  G. Zaman,et al.  High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.

[10]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[11]  S. Scheff,et al.  Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. , 1999, Journal of neurotrauma.

[12]  G. Giovannoni,et al.  A specific ELISA for measuring neurofilament heavy chain phosphoforms. , 2003, Journal of immunological methods.

[13]  R. Anderson,et al.  High serum S100B levels for trauma patients without head injuries. , 2001, Neurosurgery.

[14]  J. Troncoso,et al.  The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain , 1991, Neurochemical Research.

[15]  S. Scheff,et al.  Intermediate filament change in astrocytes following mild cortical contusion , 1996 .

[16]  E. Jauch,et al.  C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome , 2002, Brain Research.

[17]  G. Plant,et al.  Axonal degeneration and inflammation in acute optic neuritis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  L. Sternberger,et al.  Phosphorylation protects neurofilaments against proteolysis , 1987, Journal of Neuroimmunology.

[19]  E. Jauch,et al.  Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. , 2002, Annals of emergency medicine.

[20]  G. Shaw,et al.  A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF‐M and NF‐H , 1991, Journal of neuroscience research.

[21]  C. Mirkin,et al.  Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Huentelman,et al.  Characterization of mitotic neurons derived from adult rat hypothalamus and brain stem. , 2002, Journal of neurophysiology.

[23]  G. Shaw,et al.  The immunological relatedness of neurofilament proteins of higher vertebrates. , 1984, European journal of cell biology.

[24]  Alexander Sasha Rabchevsky,et al.  Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats , 2000, Neuroscience.

[25]  M. Mattson,et al.  Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. , 1998, Journal of neurotrauma.

[26]  S. Scheff,et al.  Cytochrome c release and caspase activation after traumatic brain injury , 2002, Brain Research.

[27]  B. Romner,et al.  Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. , 2003, Restorative neurology and neuroscience.

[28]  M. Strong,et al.  Phosphorylation state of the native high‐molecular‐weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis , 2001, Journal of neurochemistry.

[29]  T. Kudo,et al.  Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system , 1999, Psychiatry and clinical neurosciences.

[30]  M. Smith,et al.  Neurofilament proteins in neurodegenerative diseases , 2004, Cellular and Molecular Life Sciences CMLS.

[31]  L. Otvos,et al.  Identification of the major multiphosphorylation site in mammalian neurofilaments. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Welch.  The structure , 1992 .

[33]  H. Pant.  Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. , 1988, The Biochemical journal.

[34]  W. Schlaepfer,et al.  An Immunoblot Study of Neurofilament Degradation In Situ and During Calcium‐Activated Proteolysis , 1985, Journal of neurochemistry.

[35]  B. Romner,et al.  Biochemical serum markers of traumatic brain injury. , 2002, The Journal of trauma.

[36]  A. Polson,et al.  Isolation of IgY from the yolks of eggs by a chloroform polyethylene glycol procedure. , 1990, Immunological investigations.

[37]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[38]  J. A. Gruner,et al.  A monitored contusion model of spinal cord injury in the rat. , 1992, Journal of neurotrauma.

[39]  B. Pike,et al.  Characterization of the bovine neurofilament NF-M protein and cDNA sequence, and identification of in vitro and in vivo calpain cleavage sites. , 2004, Biochemical and biophysical research communications.

[40]  M. Verbeek,et al.  An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid. , 2005, Journal of immunological methods.

[41]  Ammar Al-Chalabi,et al.  Neurofilaments and neurological disease. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  B. Pike,et al.  Temporal Profile and Cell Subtype Distribution of Activated Caspase‐3 Following Experimental Traumatic Brain Injury , 2000, Journal of neurochemistry.